Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

Del Poeta G, Del Principe MI, Maurillo L, Rossi FM, Buccisano F, Ammatuna E, Simotti C, Zucchetto A, Catalano G, Bulian P, Bruno A, Venditti A, De Fabritiis P, Gattei V, Amadori S.

Leuk Lymphoma. 2010 Jan;51(1):95-106. doi: 10.3109/10428190903350421.

PMID:
20001236
2.

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.

Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S.

Blood. 2006 Aug 1;108(3):853-61. Epub 2006 Apr 6.

3.

Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.

Kay S, Herishanu Y, Pick M, Rogowski O, Baron S, Naparstek E, Polliack A, Deutsch VR.

Cytometry B Clin Cytom. 2006 Jul 15;70(4):218-26.

4.

Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.

Rossi FM, Del Principe MI, Rossi D, Irno Consalvo M, Luciano F, Zucchetto A, Bulian P, Bomben R, Dal Bo M, Fangazio M, Benedetti D, Degan M, Gaidano G, Del Poeta G, Gattei V.

J Transl Med. 2010 Mar 8;8:23. doi: 10.1186/1479-5876-8-23.

5.
6.

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.

Nückel H, Frey UH, Bau M, Sellmann L, Stanelle J, Dürig J, Jöckel KH, Dührsen U, Siffert W.

Blood. 2007 Jan 1;109(1):290-7. Epub 2006 Sep 7.

7.

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.

Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D.

Cancer. 2005 Nov 15;104(10):2124-32.

8.

Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.

Del Principe MI, Del Poeta G, Venditti A, Buccisano F, Maurillo L, Marini R, Cox MC, Panetta P, Suppo G, Degan M, Bruno A, Gattei V, Amadori S.

Haematologica. 2004 Dec;89(12):1468-75.

9.

Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.

Klobusická M, Kusenda J, Babusíková O.

Neoplasma. 2002;49(6):387-93.

PMID:
12584586
10.

ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia.

Vener C, Gianelli U, Cortelezzi A, Fracchiolla NS, Somalvico F, Savi F, Pasquini MC, Bosari S, Deliliers GL.

Leuk Lymphoma. 2006 Feb;47(2):245-51.

PMID:
16321853
11.

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

Dürig J, Nückel H, Cremer M, Führer A, Halfmeyer K, Fandrey J, Möröy T, Klein-Hitpass L, Dührsen U.

Leukemia. 2003 Dec;17(12):2426-34.

PMID:
14523469
12.

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.

Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V.

Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.

PMID:
19318232
13.

Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.

Passam F, Tachynopoulou V, Skoumi D, Tsompanakou A, Stavropoulos-Giokas A, Vadikolia C, Anagnostopoulos A, Paterakis G.

Ann Hematol. 2006 Nov;85(11):795-805. Epub 2006 Jul 27.

PMID:
16871389
14.

Clinical significance of CD38 expression in chronic lymphocytic leukemia.

Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S.

Blood. 2001 Nov 1;98(9):2633-9.

15.

Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.

Carreras J, Villamor N, Colomo L, Moreno C, Ramón y Cajal S, Crespo M, Tort F, Bosch F, López-Guillermo A, Colomer D, Montserrat E, Campo E.

J Pathol. 2005 Mar;205(4):507-13.

PMID:
15685592
16.

Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.

Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC; GEIL.

Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622. Epub 2008 Jan 26.

17.

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

Faderl S, Keating MJ, Do KA, Liang SY, Kantarjian HM, O'Brien S, Garcia-Manero G, Manshouri T, Albitar M.

Leukemia. 2002 Jun;16(6):1045-52.

18.

High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.

Wolowiec D, Wojtowicz M, Ciszak L, Kosmaczewska A, Frydecka I, Potoczek S, Urbaniak-Kujda D, Kapelko-Slowik K, Kuliczkowski K.

Eur J Haematol. 2009 Apr;82(4):260-6. doi: 10.1111/j.1600-0609.2008.01196.x. Epub 2009 Jan 6.

PMID:
19187271
19.

Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.

Bogner C, Sandherr M, Perker M, Weick K, Ringshausen I, Peschel C, Decker T.

Ann Hematol. 2006 Jul;85(7):458-62. Epub 2006 Mar 15.

PMID:
16538501
20.

Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.

Sheridan R, Mounajjed T, Ehrmann DE, Hurtubise PE, Schrager JA.

Cytometry B Clin Cytom. 2006 Jul 15;70(4):320-1.

Supplemental Content

Support Center